Pfizer (PFE) Revenue — Quarter Ended Apr 2, 2023
Revenue for the reported quarter declined compared to both the immediately preceding quarter and the same quarter one year earlier. This marks a continued downward trend from the prior period.
Key takeaway
Quarter ended Apr 2, 2023 · FY2023 Q1
Revenue for the reported quarter declined compared to both the immediately preceding quarter and the same quarter one year earlier. This marks a continued downward trend from the prior period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$18.5B
Revenue reported for this quarter.
Quarter-over-quarter
-26.5%
Change from the immediately preceding quarter.
Year-over-year
-28.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$94B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jul 3, 2022 | $27.7B | +46.8% |
| Oct 2, 2022 | $22.6B | -5.8% |
| Dec 31, 2022 | $25.1B | +55.3% |
| Apr 2, 2023 | $18.5B | -28.0% |
Revenue performance
The reported revenue decreased sequentially from the prior quarter, reflecting a weakening in the quarter's performance.
Quarterly comparison
Compared to the same quarter one year earlier, revenue also contracted, showing a year-over-year decline.
What to watch
The sequential and year-over-year revenue declines suggest a need to monitor whether the downward trajectory continues in coming quarters.